Preventing Illness And Death From Severe Influenza In Australia
Funder
National Health and Medical Research Council
Funding Amount
$1,719,110.00
Summary
Influenza and its complications are a common cause of hospitalisation and death. However, influenza is a moving target, with viruses constantly mutating from season to season. My research programme will transform the prevention and treatment of influenza and its complications by developing innovative public health and treatment strategies that can be applied globally. The work will optimise vaccine and treatment strategies to reduce illness and deaths from influenza.
Tuberculosis Elimination In Australia Through Targeting Latent Infection
Funder
National Health and Medical Research Council
Funding Amount
$950,000.00
Summary
Australia has committed to reducing the number of people who become sick with tuberculosis (TB), towards eventual elimination. Identification of those at risk is needed, which means significant expansion of detection and treatment of latent TB. This research will evaluate impact, cost-effectiveness and community priorities around TB elimination, and introduce a GP-based treatment service for safe and accessible care. It will provide a basis for large-scale programs towards TB elimination.
Building Decision Support Systems To Combat Emerging Infectious Diseases And Neglected Tropical Diseases: A Precision Public Health Approach
Funder
National Health and Medical Research Council
Funding Amount
$1,562,250.00
Summary
Emerging infectious diseases and neglected tropical diseases cause significant disease burden globally, and pose major health security threats in the Asia Pacific. The frequency and severity of disease outbreaks are increasing, mostly driven by environmental and socio-demographic change. My research program will use cutting-edge technologies and analytics to develop interactive, dynamic and user-friendly decision support systems that optimise surveillance and control of infectious diseases.
Prediction Of Fracture By Clinico-genetic Profiling
Funder
National Health and Medical Research Council
Funding Amount
$2,339,215.00
Summary
The loss of bone with advancing age is the main cause of osteoporosis and bone fracture. Bone loss is highly variable between individuals, and we are not sure why. I want to find out factors that contribute to bone loss, and then use this knowledge to identify individuals at high risk of excessive bone loss for early prevention. My goal over the next 5 years is to create a new clinico-genetic model for assessing the rate of bone loss, and predicting the risk of fracture for an individual.
Improving Cardiovascular Outcomes Through Better Trials
Funder
National Health and Medical Research Council
Funding Amount
$1,714,215.00
Summary
Randomised trials are the cornerstone of high quality medical practice. There is an urgent need to do more trials but there are major challenges - timely recruitment of participants, inclusion of representative patients and control of costs are issues we face every day. I will commence a series of new trials evaluating interventions for cardiovascular disease. In parallel I will develop and test innovative solutions to the practicalities of doing large-scale studies.
A Risk Stratification Tool For The Prevention Of Avoidable Perinatal Mortality And Morbidity
Funder
National Health and Medical Research Council
Funding Amount
$645,205.00
Summary
Stillbirth is more common in Australia than in some high-income countries. Babies born early may experience lung or other problems. Many current stillbirths and preterm birth can be prevented. Using a cohort of >4.5 million births from WA, NSW, SA and NT (N >4.5 million), this project will develop a strategy to predict the risk of stillbirth, preterm birth, and low birth weight. Better identification of risk in pregnancy will improve antenatal care to reduce stillbirth and neonatal morbidi ....Stillbirth is more common in Australia than in some high-income countries. Babies born early may experience lung or other problems. Many current stillbirths and preterm birth can be prevented. Using a cohort of >4.5 million births from WA, NSW, SA and NT (N >4.5 million), this project will develop a strategy to predict the risk of stillbirth, preterm birth, and low birth weight. Better identification of risk in pregnancy will improve antenatal care to reduce stillbirth and neonatal morbidity.Read moreRead less
In Australia 2 in 3 adults live with overweight or obesity and unhealthy diet is the major modifiable contributor to death and disability. We know that retail marketing strategies like food product packaging, pricing and other promotions have a major impact on what we choose to buy and eat. My research program aims to build the novel evidence required to implement effective strategies to improve the healthiness of food provision at scale.
Healthy Lungs For Life: A Life Course Approach To Reduce COPD
Funder
National Health and Medical Research Council
Funding Amount
$2,491,398.00
Summary
Chronic Obstructive Lung Disease (COPD) causes breathing distress, disability and premature death. I have shown that COPD mostly has its origins in childhood. This means we can now identify early life risk factors to prevent COPD or help us catch it early, to improve health. My 5-year vision is to reduce the dire burden of COPD by creating evidence to change guidelines and policy and facilitating the transfer of that knowledge to practice.
Delineating The Role Of Fludrocortisone And Hydrocortisone In The Management Of Patients With Septic Shock
Funder
National Health and Medical Research Council
Funding Amount
$553,664.00
Summary
Sepsis and septic shock are leading causes of morbidity and mortality globally. Steroids have been used to treat septic shock for decades. Two new trials, one using hydrocortisone vs. placebo and another using hydrocortisone plus fludrocortisone vs. placebo have produced differing results, with fludrocortisone possibly conferring a mortality benefit. My Program will investigate this evidence gap by providing critical evidence for the design and execution of a future definitive trial.
Realising The World Health Organisation Targets For Elimination Of Cervical Cancer As A Public Health Problem: Effective Implementation And Scale-up Of HPV Vaccination And Cervical Screening In Australia, Regionally, And Globally
Funder
National Health and Medical Research Council
Funding Amount
$2,125,000.00
Summary
This fellowship focuses on improving cancer screening, particularly the implementation of HPV vaccination and cervical screening. CI Canfell will pursue an Australian, regional and global health agenda towards the elimination of cervical cancer. Her work is supporting the successful implementation of the new cervical screening program in Australia, provides crucial support to other countries in the region, and is directly informing the WHO global elimination strategy.